Anthropic IPO: China and Hong Kong Investors Face Restrictions on Share Orders

Institutional investors based in mainland China and Hong Kong are facing restrictions on placing orders in Anthropic’s upcoming initial public offering (IPO), highlighting how growing tensions between the United States and China are influencing access to major technology investments. Several banks involved in the offering have reportedly refused to accept orders from investors in the two markets or warned that securing share allocations would be highly unlikely, according to people familiar with the matter cited by Bloomberg.

The restrictions are reportedly linked partly to US International Traffic in Arms Regulations (ITAR), which govern the export and trade of certain defence-related technologies. The development comes as Anthropic prepares to list on the Nasdaq under the ticker symbol ANT. The company behind the Claude artificial intelligence platform is targeting a valuation of approximately $1.4 trillion, with its IPO and concurrent private placement forming one of the largest technology-market transactions in history.

China and Hong Kong Investors Face Anthropic IPO Restrictions

According to a Bloomberg report published on November 13, several banks involved in Anthropic’s IPO have either declined to accept orders from institutional investors in mainland China and Hong Kong or indicated that allocations for these investors are unlikely.

The information comes from people familiar with the matter who requested anonymity because the restrictions have not been publicly detailed by the parties involved.

The reported restrictions are partly associated with ITAR, US regulations that control the export and transfer of defence-related products, services and technologies. Some people familiar with the offering said verbal communications with the syndicate team responsible for allocating Anthropic shares indicated that these rules prevent investors from the China region from participating.

However, the situation is not necessarily a blanket prohibition on every investor connected to China or Hong Kong. The restrictions described in the reporting concern institutional investors based in those markets and the ability of banks to accept orders and allocate shares.

Anthropic has not publicly issued a separate statement confirming the restrictions. A company representative declined to comment on the report.

Why US Defence-Trade Rules Matter

The restrictions highlight the growing overlap between artificial intelligence development, national security and international investment regulations.

ITAR is administered by the US State Department and establishes controls over the export and transfer of certain defence-related technologies and technical information. Although Anthropic is an AI company rather than a traditional defence manufacturer, its technology has become relevant to national security discussions in the United States.

The company has faced scrutiny over its relationship with the US government and the potential use of advanced AI systems in sensitive applications.

Anthropic is also involved in a legal dispute concerning the Pentagon’s designation of the company as a supply-chain risk to US national security. The dispute has brought additional attention to the company’s relationship with federal agencies and the broader debate over how advanced AI technology should be controlled.

In its IPO prospectus, Anthropic identified increasing US government scrutiny of AI companies’ exposure to Chinese state actors and escalating tensions between Washington and Beijing as risks to its business.

The reported restrictions on Chinese and Hong Kong investors therefore reflect wider concerns about who can access ownership in companies developing strategically important AI technology.

Anthropic IPO Mirrors SpaceX’s Investor Restrictions

The reported restrictions resemble the approach used during SpaceX’s $86.2 billion IPO earlier in 2026.

During that offering, syndicate banks were reportedly instructed not to accept orders from investors based in mainland China and Hong Kong because of ITAR-related concerns.

The restrictions did not necessarily prevent investors in those markets from purchasing shares after the company began trading publicly. Instead, they affected participation in the IPO allocation process.

Anthropic’s situation follows a similar pattern. Banks involved in the offering have reportedly been advised that investors from mainland China and Hong Kong may not receive allocations, even if they attempt to place orders through participating institutions.

The comparison illustrates how US companies operating in strategically sensitive technology sectors may face additional restrictions when distributing shares internationally.

However, the precise legal and contractual basis for Anthropic’s reported restrictions has not been fully disclosed publicly.

Some Investors Explore Offshore Structures

Despite the restrictions, some investors are reportedly exploring alternative ways to participate in Anthropic’s IPO.

Bloomberg reported that a family office connected to a Chinese technology founder was attempting to place an order through a trust registered in the British Virgin Islands.

Other investors are considering special purpose vehicles (SPVs), offshore holding companies and swap arrangements to gain exposure to the offering.

Hong Kong-based institutions may also explore bidding through offshore structures, although the final allocation decisions remain with Anthropic and the banks managing the transaction.

These arrangements do not guarantee access to the IPO. Investors may still face regulatory, compliance and eligibility restrictions depending on their ownership structures, beneficial ownership and the rules applied by the underwriters.

The use of offshore entities can also create additional due diligence requirements for financial institutions, particularly when the ultimate beneficial owner is based in a restricted jurisdiction.

Anthropic Targets Up to $90.4 Billion Through IPO and Private Placement

The restrictions come as Anthropic prepares for a major public-market debut.

The company and its co-founders are seeking to raise as much as $90.4 billion through the IPO and a concurrent private placement, with a targeted valuation of approximately $1.4 trillion.

Goldman Sachs and Morgan Stanley are leading the offering, alongside other participating financial institutions.

The shares are expected to be priced on November 18, 2026, ahead of trading on the Nasdaq Global Select Market on November 19 under the ticker symbol ANT.

Demand for the offering has reportedly been strong. People familiar with the matter told Bloomberg that prospective investors had expressed interest equivalent to approximately six times the shares available.

This level of demand indicates significant investor appetite for exposure to Anthropic, despite recent volatility in AI-related stocks and concerns about the high valuations attached to technology companies.

The IPO is also attracting attention because it gives public-market investors an opportunity to invest directly in one of the leading developers of advanced AI models.

Anthropic’s China Restrictions Extend Beyond the IPO

The reported investor restrictions are part of a broader separation between Anthropic and the Chinese market.

The company’s Claude products are not officially available in mainland China or Hong Kong. Anthropic has also taken steps to block access by people travelling to those locations.

These restrictions reflect the company’s approach to operating in markets where regulatory, security and geopolitical considerations may create additional risks.

The company has identified geopolitical tensions and government scrutiny involving Chinese state actors as material risks in its IPO disclosures.

For Anthropic, limiting access to its products and restricting certain investment participation may help manage regulatory exposure in a sensitive international environment.

However, the restrictions also demonstrate the challenges facing global technology companies as they navigate competing regulatory frameworks and national security priorities.

The Bigger Picture

Anthropic’s IPO restrictions illustrate how geopolitical tensions are increasingly influencing global capital markets. Traditionally, major US technology IPOs attracted institutional investors from a wide range of international markets. However, companies developing advanced AI, semiconductor technology and other strategically important products may face additional scrutiny over the identity and location of their investors.

The distinction between owning shares and accessing sensitive technology is also important. The reported restrictions concern participation in the IPO allocation process and should not automatically be interpreted as a permanent ban on all secondary-market purchases by investors connected to China or Hong Kong.

For global financial institutions, the situation creates additional compliance challenges. Banks must assess not only investor eligibility but also beneficial ownership, regulatory exposure and the potential consequences of facilitating transactions involving sensitive technology companies.

Looking Ahead

Anthropic’s IPO is scheduled to price on November 18, with shares expected to begin trading on Nasdaq the following day. The reported restrictions could limit participation by some institutional investors in mainland China and Hong Kong, although offshore structures may provide alternative routes for certain investors if they satisfy the applicable requirements. The final allocation process will determine how strictly these restrictions are applied.

The development also highlights a broader challenge for international investors seeking exposure to the AI industry. As artificial intelligence becomes increasingly important to national security and economic competitiveness, investment access may be shaped as much by geopolitical considerations as by financial demand. Anthropic’s public listing could become another example of how technology-sector IPOs are being influenced by the growing divide between the United States and China.